Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
598.00    -6.00 (-0.99%)
Bid:
596.00
Ask:
598.00
Spread: 2.00 (0.336%)
Market Cap: £521.00m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Management Change

27 Apr 2012 07:00

RNS Number : 1795C
Victrex PLC
27 April 2012
 



27 April 2012

 

Victrex plc

 

Management Change

 

Victrex plc ("the Company") today announces that Hichem M'Saad has been appointed as Managing Director of our Invibio® Biomaterial Solutions business unit ("Invibio"). Hichem will join the Company on 18 June 2012, succeeding Michael Callahan, who will remain on the Invibio board as leader of the spine business.

 

Prior to joining Invibio Hichem's career included 14 years at Applied Materials Inc, most recently as Corporate Vice President and General Manager of their Silicon Sector Group. Hichem holds a PhD in Materials Science and Engineering from the Massachusetts Institute of Technology and has extensive commercial and technical experience globally, in both start-up and mature businesses.

David Hummel, Chief Executive said:

 

"I am delighted that Hichem is joining Invibio. His wealth of general management and commercial experience in technology driven businesses will enable him to lead Invibio into a new phase of growth and realise opportunities in new and existing market areas. He will be a valuable asset to both Invibio and the wider Victrex Group.

 

I would like to thank Michael for his contribution to the Invibio business since its launch in 2001. Michael has supported us through a period of significant growth, development and investment, and will continue to deliver Invibio's strategy in the spine business going forward."

 

 

Enquiries

 

Victrex plc

01253 898067

David Hummel, Chief Executive

Steve Barrow, Finance Director

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne

0203 128 8100

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGPCUPPGAQ
Date   Source Headline
30th Nov 20161:30 pmRNSTotal Voting Rights
17th Nov 20162:19 pmRNSDirector/PDMR Shareholding
10th Nov 201611:11 amRNSAdditional Listing
31st Oct 20162:39 pmRNSTotal Voting Rights
18th Oct 20162:10 pmRNSDirector/PDMR Shareholding
11th Oct 20167:00 amRNSTrading Statement
30th Sep 20161:11 pmRNSTotal Voting Rights
19th Sep 20164:28 pmRNSDirector/PDMR Shareholding
19th Sep 20163:18 pmRNSHolding(s) in Company
31st Aug 20169:28 amRNSTotal Voting Rights
17th Aug 20163:46 pmRNSDirector/PDMR Shareholding
29th Jul 20162:47 pmRNSTotal Voting Rights
28th Jul 20162:57 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Management Statement
19th Jul 20164:34 pmRNSDirector/PDMR Shareholding
30th Jun 201610:00 amRNSTotal Voting Rights
17th Jun 20163:56 pmRNSDirector/PDMR Shareholding
14th Jun 20164:42 pmRNSHolding(s) in Company
14th Jun 20164:24 pmRNSHolding(s) in Company
1st Jun 20169:02 amRNSBlock listing Interim Review
31st May 201611:42 amRNSTotal Voting Rights
26th May 20164:26 pmRNSHolding(s) in Company
17th May 20164:11 pmRNSDirector/PDMR Shareholding
16th May 20167:00 amRNSHalf-year Report
3rd May 20163:27 pmRNSHolding(s) in Company
3rd May 20163:15 pmRNSHolding(s) in Company
3rd May 20163:00 pmRNSHolding(s) in Company
29th Apr 201610:00 amRNSTotal Voting Rights
28th Apr 20167:00 amRNSResolution of US FTC inquiry
21st Apr 20167:00 amRNSDirector Declaration
19th Apr 201611:07 amRNSDirector/PDMR Shareholding
7th Apr 20167:00 amRNSTrading Statement
31st Mar 20162:51 pmRNSTotal Voting Rights
31st Mar 20161:45 pmRNSTotal Voting Rights
17th Mar 201610:15 amRNSDirector/PDMR Shareholding
1st Mar 20165:00 pmRNSDirector/PDMR Shareholding
29th Feb 20162:18 pmRNSTotal Voting Rights
26th Feb 20163:09 pmRNSHome Member State
17th Feb 201611:27 amRNSDirector/PDMR Shareholding
10th Feb 20163:55 pmRNSResult of AGM
10th Feb 20167:00 amRNSAGM Statement
9th Feb 20164:44 pmRNSHolding(s) in Company
5th Feb 20161:38 pmRNSGrant of Options
29th Jan 20169:27 amRNSTotal Voting Rights
19th Jan 201611:39 amRNSDirector/PDMR Shareholding
19th Jan 201610:08 amRNSDirector Declaration
5th Jan 201612:00 pmRNSAnnual Financial Report
31st Dec 201510:00 amRNSTotal Voting Rights
17th Dec 20154:23 pmRNSHolding(s) in Company
17th Dec 20153:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.